Author:
Chen Xiaoyue,Zhang Minjie,Gan Haiyun,Wang Heping,Lee Jeong-Heon,Fang Dong,Kitange Gaspar J.,He Lihong,Hu Zeng,Parney Ian F.,Meyer Fredric B.,Giannini Caterina,Sarkaria Jann N.,Zhang Zhiguo
Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry
Reference53 articles.
1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl. J. Med. 352, 987–996 (2005).
2. Stupp, R. et al. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann. Oncol. 25, iii93–iii101 (2014).
3. Kitange, G. J. et al. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts. Neuro. Oncol. 11, 281–291 (2009).
4. Everhard, S. et al. Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro. Oncol. 11, 348–356 (2009).
5. Moradi, M. et al. The prognostic value of MGMT promoter methylation in glioblastoma: a meta-analysis of clinical trials. J. Cell. Physiol. 233, 378-386 (2018).
Cited by
194 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献